[FG] Dieterle Thomas

Kröpfl, Julia M. et al. (2023) ‘Circulating Gal-3 and sST2 are associated with acute exercise-induced sustained endothelial activation: Possible relevance for fibrosis development?’, Experimental Physiology, 108, pp. 1259–1267. Available at: https://doi.org/10.1113/ep091277.

Dieterle T. (2022) ‘«Deprescribing» von Benzodiazepin-Rezeptor-Agonisten’, Prim Hosp Care Allg Inn Med, 22(12), pp. 380–384.

Züsli S et al. (2021) ‘Point of care with serial NT-proBNP measurement in patients with acute decompensated heart failure as a therapy-monitoring during hospitalization (POC-HF): Study protocol of a prospective, unblinded, randomized, controlled pilot trial.’, Contemporary clinical trials communications, 23, p. 100825. Available at: https://doi.org/10.1016/j.conctc.2021.100825.

Marmy JL et al. (2021) ‘Adherence to GOLD Recommendations among Swiss Pulmonologists and General Practitioners.’, COPD, 18(1), pp. 9–15. Available at: https://doi.org/10.1080/15412555.2020.1859469.

Gasser B.A. et al. (2021) ‘High-Intensity Interval Training for Heart Failure Patients With Preserved Ejection Fraction (HIT-HF)-Rational and Design of a Prospective, Randomized, Controlled Trial’, Frontiers in Physiology, 12. Available at: https://doi.org/10.3389/fphys.2021.734111.

Minoski, D. and Dieterle, T. (2021) ‘Dyslipidaemia and hypertension - brothers in crime?!’, Cardiovascular Medicine, 24. Available at: https://doi.org/10.4414/cvm.2021.02177.

Dieterle T et al. (2020) ‘Introduction of sacubitril/valsartan in primary care follow-up of heart failure: a prospective observational study (THESEUS).’, ESC heart failure, 7(4), pp. 1626–1634. Available at: https://doi.org/10.1002/ehf2.12716.

Giezendanner S et al. (2020) ‘Effect of guideline revisions by the Swiss Society of Hypertension on blood pressure control in hypertensive patients from primary care.’, Swiss medical weekly, 150, p. w20279. Available at: https://doi.org/10.4414/smw.2020.20279.

Gregoriano, Claudia et al. (2019) ‘Does a tailored intervention to promote adherence in patients with chronic lung disease affect exacerbations? A randomized controlled trial’, Respiratory research, 20(1), p. 273. Available at: https://doi.org/10.1186/s12931-019-1219-3.

Handschin, Anja et al. (2019) ‘Cardiovascular risk stratification in primary care patients with arterial hypertension: Results from the Swiss Hypertension Cohort Study (HccH)’, European Journal of Preventive Cardiology, 26(17), pp. 1843–1851. Available at: https://doi.org/10.1177/2047487319856732.

Kind, Sara et al. (2019) ‘Factors associated with cardiorespiratory fitness in a Swiss working population’, Journal of Sports Medicine, 2019, p. 5317961. Available at: https://doi.org/10.1155/2019/5317961.

Urwyler, Pascal et al. (2019) ‘Predictive factors for exacerbation and re-exacerbation in chronic obstructive pulmonary disease: an extension of the Cox model to analyze data from the Swiss COPD cohort’, Multidisciplinary respiratory medicine, 14(7), p. 7. Available at: https://doi.org/10.1186/s40248-019-0168-5.

Wagner, Jonathan et al. (2019) ‘Functional aging in health and heart failure: the COmPLETE Study’, BMC Cardiovascular Disorders, 19(1), p. 180. Available at: https://doi.org/10.1186/s12872-019-1164-6.

Peters, Nils and Dieterle,Thomas (2019) ‘Ursachen und klinische Relevanz von Blutdruckvariabilität.’, Der informierte Arzt, 9(5), pp. 23–26.

Marmy, Joana et al. (2018) ‘COPD GOLD 2017 guidelines adherence in Swiss pulmologists and general practitioners’. EUROPEAN RESPIRATORY SOC JOURNALS LTD, 52. Available at: https://doi.org/10.1183/13993003.congress-2018.pa911.

Naduvilekoot, A. et al. (2018) ‘DISCREPANCIES IN CARDIOVASCULAR RISK STRATIFICATION IN HYPERTENSIVE PATIENTS - RESULTS FROM THE SWISS HYPERTENSION COHORT STUDY (HCCH)’. LIPPINCOTT WILLIAMS & WILKINS, 36.

Bierreth, Frederick, Gregoriano, Claudia and Dieterle, Thomas (2018) ‘Ein erster Blick auf die neuen europäischen Hypertonie-Guidelines’, Primary and Hospital Care, 18(15), pp. 265–269. Available at: https://doi.org/10.4414/phc-d.2018.01803.

Gregoriano, Claudia et al. (2018) ‘Use and inhalation technique of inhaled medication in patients with asthma and COPD: data from a randomized controlled trial’, Respiratory research, 19(1), p. 237. Available at: https://doi.org/10.1186/s12931-018-0936-3.

Gregoriano, C. et al. (2017) Prescription and use of inhaled medication in patients with asthma and COPD: Baseline-data of an adherence-Intervention-study. JMIR Publications Inc. Available at: https://doi.org/10.2196/preprints.9246.

Thesenvitz, Elke et al. (2017) ‘Predictors for a COPD exacerbation - Data analysis of the Swiss COPD Cohort study (SCCS)’. SPRINGER WIEN, 129.

Thesenvitz, Elke et al. (2017) ‘Combination therapy in the Swiss COPD Cohort Study (SCCS) - An interim analysis’. SPRINGER WIEN, 129.

Giezendanner, S. et al. (2017) ‘CARDIOVASCULAR RISK FACTORS IN A HYPERTENSIVE POPULATION IN PRIMARY CARE IN SWITZERLAND’. LIPPINCOTT WILLIAMS & WILKINS, 35.

Janisch, B. et al. (2017) ‘THE RELATION OF ARTERIAL HYPERTENSION AND TARGET ORGAN DAMAGE IN’. LIPPINCOTT WILLIAMS & WILKINS, 35.

Thesenvitz, E. et al. (2017) ‘HIGH-INTENSITY INTERVAL TRAINING AS TREATMENT STRATEGY FOR HEART FAILURE PATIENTS WITH PRESERVED EJECTION FRACTION: A PROTOCOL PROPOSAL FOR A RANDOMIZED CONTROLLED TRIAL’. LIPPINCOTT WILLIAMS & WILKINS, 35.

Binder, Carmen et al. (2017) ‘Costs and benefits of diagnostic testing: four ways to improve patient care by purposive use of in vitro diagnostics’, Swiss medical weekly, 147, p. w14546. Available at: https://doi.org/10.4414/smw.2017.14546.

Carron, Tania et al. (2017) ‘Feasibility, acceptability and effectiveness of integrated care for COPD patients: a mixed methods evaluation of a pilot community-based programme’, Swiss medical weekly, 147, p. w14567. Available at: https://doi.org/10.4414/smw.2017.14567.

Gregoriano, Claudia et al. (2017) ‘Impact of an electronic monitoring intervention to improve adherence to inhaled medication in patients with asthma and Chronic Obstructive Pulmonary Disease: Study Protocol for a Randomized Controlled Trial’, JMIR Research Protocols, 6(10), p. e204. Available at: https://doi.org/10.2196/resprot.7522.

Mundwiler, Jonas et al. (2017) ‘Association of Occupational and Leisure-Time Physical Activity with Aerobic Capacity in a Working Population’, PLoS ONE, 12(1), p. e0168683. Available at: https://doi.org/10.1371/journal.pone.0168683.

Allemann, Yves et al. (2017) ‘Hypertonie - Essenz und Evidenz’, in Battegay, Edouard; Martina; Benedict; Schmidt, Dörthe; Elke, Barbara (ed.) Hypertonie - Essenz und Evidenz. 2 edn. Hogrefe (Hypertonie - Essenz und Evidenz).

Karl, Johann et al. (2016) ‘Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial.’, JACC. Heart failure. 12.10.2016, 4(11), pp. 860–869. Available at: https://doi.org/10.1016/j.jchf.2016.08.002.

Gregoriano, Claudia et al. (2016) ‘Patients” adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial’. SPRINGER, 38.

Buess, D. et al. (2016) ‘FIXED-DOSE COMBINATIONS OF ANTIHYPERTENSIVE DRUGS MAY NOT IMPROVE BLOOD PRESSURE CONTROL COMPARED TO FREE DRUG COMBINATIONS - FINDINGS FROM THE SWISS HYPERTENSION COHORT STUDY’. LIPPINCOTT WILLIAMS & WILKINS, 34.

Gerhards C et al. (2016) ‘Asthma.’, Praxis, 105(18), pp. 1099–102. Available at: https://doi.org/10.1024/1661-8157/a002463.

Schuepbach, U. et al. (2016) ‘THE ASSOCIATION OF BLOOD PRESSURE AND BODY COMPOSITION MEASURES WITH MAXIMAL AEROBIC CAPACITY IN A SWISS WORKING POPULATION’. LIPPINCOTT WILLIAMS & WILKINS, 34.

Latini, Roberto et al. (2016) ‘Biomarkers for risk prediction of mortality’. Edited by World Intellectual Property Organization, (PCT/EP2015/075012).

Dieterle,Thomas et al. (2016) ‘Biomarkers and methods of prediction’. Edited by World Intellectual Property Office, (PCT/EP2015/074242).

Brighenti-Zogg, Stefanie et al. (2016) ‘Physical Workload and Work Capacity across Occupational Groups’, PloS one, 11(5), p. e0154073. Available at: https://doi.org/10.1371/journal.pone.0154073.

Gerhards C. et al. (2016) ‘«Husten – wir haben ein Problem».’, Praxis, 105(21), pp. 1273–1275. Available at: https://doi.org/10.1024/1661-8157/a002496.

Gerhards C. et al. (2016) ‘Allergic asthma and allergic rhinitis – is the evidence-based management the best way to treatment success? Allergisches Asthma und allergische Rhinitis: Evidenzbasiertes Management, das Mittel zum Erfolg?’, Therapeutische Umschau, 73(6), pp. 349–355. Available at: https://doi.org/10.1024/0040-5930/a000803.

Gerhards, Claudia et al. (2016) ‘Die chronisch-obstruktive Lungenerkrankung (COPD) im Ueberblick’, Praxis, 105(19), pp. 1151–1155. Available at: https://doi.org/10.1024/1661-8157/a002477.

Gerhards, Claudia et al. (2016) ‘Umsetzung der COPD-Guidelines in Grundversorgerpraxen’, Therapeutische Umschau. Revue therapeutique, 73(6), pp. 327–332. Available at: https://doi.org/10.1024/0040-5930/a000800.

Rohr, Ulrich-Peter et al. (2016) ‘The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report’, PloS one, 11(3), p. e0149856. Available at: https://doi.org/10.1371/journal.pone.0149856.

Allemann, Yves et al. (2016) ‘SPRINT-Studie: Stellungnahme der schweizerischen Hypertonie-Gesellschaft (SHG). Zielblutdruck: vorerst keine Aenderung der geltenden Empfehlungen.’, Swiss Medical Forum, 16, pp. 1080–1081.

Dieterle,Thomas (2016) ‘Hypertoniebehandlung nach SPRINT.’, info@herz+gefäss, 6, pp. 25–28.

Dieterle,Thomas (2016) ‘Hypertonie beim alten Menschen. Bringt die Blutdrucksenkung überhaupt einen Benefit und wie tief soll man gehen?’, Hausarzt Praxis, 3, pp. 14–18.

Gregoriano, Claudia et al. (2015) ‘Patients” adherence to chronic treatment of pulmonary diseases’. EUROPEAN RESPIRATORY SOC JOURNALS LTD, 46. Available at: https://doi.org/10.1183/13993003.congress-2015.pa1061.

Miedinger, David et al. (2015) ‘Daytime sleepiness, risk of sleep apnea and accidents in professional drivers’. EUROPEAN RESPIRATORY SOC JOURNALS LTD, 46. Available at: https://doi.org/10.1183/13993003.congress-2015.pa1173.

Block, Dirk et al. (2015) ‘Biomarkers for risk assessment and treatment monitoring in heart failure patients guided by natriuretic peptides’. Edited by World Intellectual Property Organization, (PCT/EP2015/05 1239).

Hund, Martin, Dieterle,Thomas and Lapaire,Olav (2015) ‘Prediction of postpartum HELLP syndrome, postpartum eclampsia or postpartum preeclampsia’. Edited by World Intellectual Property Organization, (PCT/EP2015/05 1457).

Dieterle T. (2015) ‘Editorial Editorial’, Therapeutische Umschau, 72(6), p. 359. Available at: https://doi.org/10.1024/0040-5930/a000686.

Handschin A. et al. (2015) ‘Hypertension in the elderly Therapie der arteriellen Hypertonie beim betagten Menschen’, Therapeutische Umschau, 72(6), pp. 397–403. Available at: https://doi.org/10.1024/0040-5930/a000692.

Handschin, A. et al. (2015) ‘HOW COMPLIANT ARE GENERAL PRACTITIONERS WITH THE EUROPEAN SOCIETY OF HYPERTENSION RISK STRATIFICATION GUIDELINES? PRELIMINARY DATA FROM THE SWISS HYPERTENSION COHORT STUDY’. LIPPINCOTT WILLIAMS & WILKINS, 33.

Block, Dirk et al. (2015) ‘Marker for statin treatment stratification in heart failure’. Edited by World Intellectual Property Organization, (PCT/EP2014/068090).

Buess, Daniel et al. (2015) ‘[Therapy-resistant arterial hypertension]’, Therapeutische Umschau. Revue therapeutique, 72(6), pp. 389–396. Available at: https://doi.org/10.1024/0040-5930/a000691.

Dieterle, Thomas (2015) ‘[Side effects and interactions of frequently used cardiovascular drugs]’, Therapeutische Umschau. Revue therapeutique, 72(11-12), pp. 701–10. Available at: https://doi.org/10.1024/0040-5930/a000740.

Handschin, Anja et al. (2015) ‘[Cardiovascular risk stratification and therapeutic implications in arterial hypertension]’, Therapeutische Umschau. Revue therapeutique, 72(6), pp. 361–8. Available at: https://doi.org/10.1024/0040-5930/a000687.

Henny-Fullin, Katja et al. (2015) ‘[Hypertensive urgency and emergency]’, Therapeutische Umschau. Revue therapeutique, 72(6), pp. 405–411. Available at: https://doi.org/10.1024/0040-5930/a000693.

Schafer, Hans Hendrik et al. (2015) ‘Bridging the Gap: The Potential Role of Corticosteroid Binding Globulin in Cardiac Steroid Facilitation’, Current Drug Targets, 16(11), pp. 1254–69. Available at: https://doi.org/10.2174/1389450116666150408103806.

Teichgräber, Volker et al. (2015) ‘Specific inhibition of fibroblast activation protein (FAP)-alpha prevents tumor progression in vitro’, Advances in Medical Sciences, 60(2), pp. 264–72. Available at: https://doi.org/10.1016/j.advms.2015.04.006.

Schaefer,Hendrik H et al. (2015) ‘The diagnostic industry in a changing health care environment’, Journal of Management Research, 15(2), pp. 91–100.

Schäfer, H Hendrik et al. (2015) ‘Medical value as a new strategy to increase corporate viability: market chances and limitations in the diagnostic industry.’, Journal of Entrepreneurship and Organization Management. 10.03.2015, 4(1). Available at: https://doi.org/10.4172/2169-026x.1000131.

Van Wijk, S. et al. (2014) ‘Biomarkers in heart failure with preserved versus reduced left ventricular ejection fraction’. WILEY-BLACKWELL, 16.

Dieterle, Thomas (2014) ‘Erectile dysfunction in arterial hypertension’, Cardiovascular medicine, 17(10), pp. 53–60. Available at: https://doi.org/10.4414/cvm.2014.00224.

Binder, Carmen et al. (2014) ‘Relevance of personalized health care in patients with arterial hypertension: where are we now?’, in Lizbeth Salazar-Sanchez (ed.) Update on Essential Hypertension. London: Intech Open (Update on Essential Hypertension), pp. 131–184. Available at: https://doi.org/10.5772/63558.

Schäfer, Hans Hendrik et al. (2013) ‘Patients with non-insulin depending diabetes mellitus and metabolic syndrome are suboptimal treated in Swiss primary care’, Clinical and experimental hypertension, 35(7), pp. 496–505. Available at: https://doi.org/10.3109/10641963.2012.758275.

Teichgräber,V and Dieterle,T (2013) ‘Arterielle Hypertonie 2013. Was gibt es Neues?’, CardioVasc, 5, pp. 4–8.

Teichgräber,Volker and Dieterle,Thomas (2013) ‘Medikamenteninteraktionen bei antihypertensiver Therapie.’, Der informierte Arzt, 6-7, pp. 30–34.

Dieterle, Thomas (2012) ‘Blood pressure measurement - an overview’, Swiss Medical Weekly, 142, p. w13517. Available at: https://doi.org/10.4414/smw.2012.13517.

Jeger, Raban and Dieterle, Thomas (2012) ‘Statins: have we found the Holy Grail?’, Swiss Medical Weekly, 142, p. w13515. Available at: https://doi.org/10.4414/smw.2012.13515.

Maeder, Micha T. et al. (2012) ‘Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy’, American heart journal, 163(3), pp. 407–14, 414.e1. Available at: https://doi.org/10.1016/j.ahj.2011.12.003.

Mamot, Christoph et al. (2012) ‘Tolerability, safety, pharmacokinetics, and efficacy of doxorubicin-loaded anti-EGFR immunoliposomes in advanced solid tumours: a phase 1 dose-escalation study’, The Lancet oncology, 13(12), pp. 1234–41. Available at: https://doi.org/10.1016/s1470-2045(12)70476-x.

Schäfer, Hans-Hendrik et al. (2012) ‘Recommendations for the treatment of hypertension in the elderly and very elderly--a scotoma within international guidelines’, Swiss medical weekly, 142, p. w13574. Available at: https://doi.org/10.4414/smw.2012.13574.

Schäfer, H. H. et al. (2012) ‘Management of hypertension in patients with diabetes mellitus and metabolic syndrome in Swiss primary care’, The international journal of clinical practice, 66(11), pp. 1125–6. Available at: https://doi.org/10.1111/ijcp.12000.

Rochlitz, C. et al. (2011) ‘A phase I study of doxorubicin-loaded anti-EGFR immunoliposomes in patients with advanced solid tumors’. KARGER, 34.

Grussenmeyer, Thomas et al. (2011) ‘Proteome analysis in cardiovascular pathophysiology using Dahl rat model’, Journal of proteomics, 74(5), pp. 672–82. Available at: https://doi.org/10.1016/j.jprot.2011.02.015.

Schaefer H.-H. and Dieterle T. (2011) ‘Diagnosis and therapy of heart failure with normal ejection fraction Diastolische herzinsuffizienz - Diagnostik und therapie’, Therapeutische Umschau, 68(2), pp. 81–87. Available at: https://doi.org/10.1024/0040-5930/a000124.

Maeder, M. T. et al. (2010) ‘Worsening renal failure in elderly patients with heart failure on intense medical therapy: clinical predictors and prognostic impact’. OXFORD UNIV PRESS, 31.

Dieterle, Thomas et al. (2010) ‘Cardiovascular risk stratification in unselected primary care patients with newly detected arterial hypertension’, Hypertension research, 33(6), pp. 607–15. Available at: https://doi.org/10.1038/hr.2010.40.

Meili-Butz, Silvia et al. (2010) ‘Acute effects of urocortin 2 on cardiac function and propensity for arrhythmias in an animal model of hypertension-induced left ventricular hypertrophy and heart failure’, European journal of heart failure, 12(8), pp. 797–804. Available at: https://doi.org/10.1093/eurjhf/hfq054.

Meili-Butz, Silvia et al. (2009) ‘Effects of Longer-Term Administration of Urocortin 2 on Left Ventricular Function and Survival in Rats With Severe Heart Failure’. LIPPINCOTT WILLIAMS & WILKINS, 120.

Meili-Butz, Silvia et al. (2009) ‘Chronic Administration of Urocortin 2 in Hypertension-Induced Hypertrophy: Effects on Intracellular Calcium Handling and Hemodynamics’. LIPPINCOTT WILLIAMS & WILKINS, 120.

Bühler, Katrin et al. (2009) ‘The human urocortin 2 gene is regulated by hypoxia : identification of a hypoxia-responsive element in the 3′-flanking region’, Biochemical journal : BJ, 424(1), pp. 119–27. Available at: https://doi.org/10.1042/bj20090311.

Dieterle, Thomas et al. (2009) ‘Immediate and sustained blood pressure lowering by urocortin 2 : a novel approach to antihypertensive therapy?’, Hypertension, 53(4), pp. 739–44. Available at: https://doi.org/10.1161/hypertensionaha.108.125211.

Eriksson, U. (2009) ‘Myeloid differentiation factor-88/interleukin-1 signaling controls cardiac fibrosis and heart failure progression in inflammatory dilated cardiomyopathy’, Circulation research : journal of the American Heart Association, 105(9), pp. 912–20. Available at: https://doi.org/10.1161/circresaha.109.199802.

Quitt, Jonas et al. (2009) ‘Does nonmedical hospital admission staff accurately triage emergency department patients?’, European journal of emergency medicine, 16(4), pp. 172–6. Available at: https://doi.org/10.1097/mej.0b013e32830c2193.

Dieterle T., Pfisterer M. and La Rocca H.B. (2008) ‘Heart failure in the elderly’, Aging Health, 4(2), pp. 137–155. Available at: https://doi.org/10.2217/1745509x.4.2.137.

Eriksson, U. (2008) ‘Prominin-1+/CD133+ bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis’, Cardiovascular research, 80(2), pp. 236–45. Available at: https://doi.org/10.1093/cvr/cvn190.

Grussenmeyer, Thomas et al. (2008) ‘Quantitative proteome analysis in cardiovascular physiology and pathology : I. Data processing’, Journal of Proteome Research, 7(12), pp. 5211–20. Available at: https://doi.org/10.1021/pr8005292.

Dieterle, Thomas et al. (2007) ‘Immediate and sustained blood pressure lowering by CRF-receptor stimulation: A novel approach to anti hypertensive therapy?’ LIPPINCOTT WILLIAMS & WILKINS, 116.

Joerg, L. et al. (2007) ‘Prevalence of severely impaired ejection fraction after percutaneous coronary intervention’. OXFORD UNIV PRESS, 28.

Dieterle, Th. and Leimenstoll, B. (2007) ‘Significantly rare leg edema during treatment with lercanidipine Signifikant seltener beinödeme unter therapie mit lercanidipin’, Praxis, 96(34), pp. 1275–1276. Available at: https://doi.org/10.1024/1661-8157.96.34.1275.

Blank R et al. (2007) ‘Images in cardiovascular medicine. Wolff-Parkinson-White syndrome and atrial fibrillation in a patient with a coronary sinus diverticulum.’, Circulation, 115(20), pp. e469–71. Available at: https://doi.org/10.1161/circulationaha.106.676866.

Coenen, M. J. et al. (2006) ‘Is ECG guided programming of optimal right-to-left ventricular delays in cardiac resynchronisation therapy feasible?’ OXFORD UNIV PRESS, 27.

Dieterle, T. et al. (2006) ‘Urocortin II: potential to improve left ventricular function in beta-adrenergic agonist resistant congestive heart failure?’ OXFORD UNIV PRESS, 27.

Dieterle, T. et al. (2006) ‘Cardiovascular risk stratification in unselected medical outpatients with newly detected arterial hypertension’. LIPPINCOTT WILLIAMS & WILKINS, 24.

Conen, David et al. (2006) ‘C-reactive protein and B-type natriuretic peptides in never-treated white coat hypertensives’, Hypertension Research, 29(6), pp. 411–5. Available at: https://doi.org/10.1291/hypres.29.411.

Conen, D. et al. (2006) ‘C-reactive protein and echocardiography have little impact on risk stratification in never-treated hypertensive patients’, Journal of human hypertension, 20(8), pp. 587–92. Available at: https://doi.org/10.1038/sj.jhh.1002048.

Leuppi, Jörg D. et al. (2006) ‘Can airway obstruction be estimated by lung auscultation in an emergency room setting?’, Respiratory medicine, 100(2), pp. 279–285. Available at: https://doi.org/10.1016/j.rmed.2005.05.005.

Martina, Benedict et al. (2006) ‘Impact of baseline echocardiography on treatment outcome in primary care patients with newly detected arterial hypertension: a randomized trial’, American journal of hypertension, 19(11), pp. 1150–5. Available at: https://doi.org/10.1016/j.amjhyper.2006.05.003.

Dieterle, T et al. (2005) ‘In vivo hemodynamic effects of urocortin II in heart failure: Comparison beta-adrenergic stimulation’. LIPPINCOTT WILLIAMS & WILKINS, 112.